CINSARC Genomic Signature as Predictor of Resectability of Ovarian Adenocarcinoma
NCT04248231
·
clinicaltrials.gov ↗
COMPLETED
Status
150
Enrollment
OTHER
Sponsor class
Conditions
Ovarian Adenocarcinoma
Interventions
OTHER:
CINSARC signature
Sponsor
Institut Claudius Regaud